您当前所在的位置:首页 > 产品中心 > 产品信息
Hydrochlorothiazide_分子结构_CAS_58-93-5)
点击图片或这里关闭

Hydrochlorothiazide

产品号 DB00999 公司名称 DrugBank
CAS号 58-93-5 公司网站 http://www.ualberta.ca/
分子式 C7H8ClN3O4S2 电 话 (780) 492-3111
分子量 297.73912 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 872

产品价格信息

请登录

产品别名

标题
Hydrochlorothiazide
IUPAC标准名
6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
IUPAC传统名
hydrochlorothiazide
商标名
Esimil
Cidrex
Ziac
Hypothiazide
Aquarills
Dichlorotride
Diu-Melusin
Drenol
Fluvin
Hidril
Hydrozide
Megadiuril
Nefrix
Servithiazid
Vetidrex
Aquarius
Bremil
Caplaril
Chlorzide
Dichlorosal
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Direma
Disalunil
Esidrex
Hidrochlortiazid
Hidroronol
Hydrothide
Jen-Diril
Neoflumen
Newtolide
Thlaretic
Timolide
Urodiazin
Acuretic
Aldoril
Apresazide
Capozide
Chlorosulthiadil
Hidrotiazida
Hydril
Hydro-Aquil
Hydro-Diuril
Hydrodiuretic
Hydropres
Hydrosaluric
Hypothiazid
Idrotiazide
Ivaugan
Lotensin Hct
Maschitt
Moduretic
Neo-Codema
Panurin
Ro-Hydrazide
Thiaretic
Thiuretic
别名
Dihydrochlorothiazidum
Dihydroxychlorothiazidum
Dihydrochlorurit
Hydrochlorothiazid
HCTZ
HCZ
Dihydrochlorurite
Dihydrochlorothiazid
Dihydrochlorothiazide
Hydrochlorthiazide

产品登记号

CAS号 58-93-5

产品性质

疏水性(logP) -0.5
溶解度 0.7 mg/mL

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. [PubChem]
Indication For the treatment of high blood pressure and management of edema.
Pharmacology Thiazides such as hydrochlorothiazide promote water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.
Toxicity The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. The oral LD50 of hydrochlorothiazide is greater than 10 g/kg in the mouse and rat.
Affected Organisms
Humans and other mammals
Biotransformation Hydrochlorothiazide is not metabolized.
Absorption 50-60%
Half Life 5.6 and 14.8 hours
Protein Binding 67.9%
Elimination Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney. Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.
External Links
Wikipedia
RxList
Drugs.com

参考文献